General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Pharmaceuticals

Innovating to treat disease more effectively

Our global Pharmaceuticals portfolio includes more than 40 key marketed products, many of which are innovative leaders in their therapeutic areas. In 2011 we received a total of 15 approvals in the United States, Europe and Japan.

Learn more about our Pharmaceuticals Division

Learn more about Novartis pharmaceuticals in your country:

Key pharmaceutical products marketed by Novartis are listed below by therapeutic area.

  • Autoinflammatory and autoimmune diseases

    Ilaris (canakinumab)

  • Hypertension

    Amturnide (aliskiren, amlodipine and hydrochlorothiazide)

    Diovan (valsartan)

    Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)

    Exforge (valsartan and amlodipine besylate)

    Exforge HCT (valsartan, amlodipine besylate and hydrochlorothiazide)

    Lescol/Lescol XL (fluvastatin sodium)

    Lotensin/Cibacen (benazepril hydrochloride)

    Lotensin HTC/Cibadrex (benazepril hydrochloride and hydrochlorothiazide)

    Lotrel (amlodipine besylate and benazepril hydrochloride)

    Tekamlo/Rasilamlo (aliskiren and amlodipine)

    Tekturna/Rasilez (aliskiren)

    Tekturna HCT/Rasilez HCT (aliskiren and hydrochlorothiazide)

  • Metabolism

    Eucreas (vildagliptin and metformin)

    Galvus (vildagliptin)

  • Virology / Anti-infectives

    Cubicin (daptomycin)

    Tyzeka / Sebivo (telbivudine)

  • Neuroscience

    Clozaril/Leponex (clozapine)

    Comtan (entacapone)

    Exelon & Exelon Patch (rivastigmine tartrate & rivastigmine transdermal system)

    Extavia (interferon beta-1b)

    Fanapt (iloperidone)

    Focalin & Focalin XR (dexmethylphenidate HCl & dexmethylphenidate modified release)

    Gilenya (fingolimod)

    Ritalin & Ritalin LA (methylphenidate HCl & methylphenidate HCl modified release)

    Stalevo (carbidopa, levodopa and entacapone)

    Tegretol (carbamazepine)

    Trileptal (oxcarbazepine)

  • Oncology

    Afinitor/Votubia (everolimus)

    Exjade (deferasirox)

    Femara (letrozole tablets/letrozole)

    Gleevec/Glivec (imatinib mesylate/imatinib)

    Sandostatin LAR & Sandostatin SC (octreotide/IM injection)

    Tasigna (nilotinib)

    Zometa (zoledronic acid)

  • Ophthalmology

    Lucentis (ranibizumab)

  • Respiratory

    Foradil (formoterol)

    Arcapta Neohaler / Onbrez Breezhaler (indacaterol)

    TOBI/TOBI Podhaler (tobramycin)

    Xolair (omalizumab)

  • Transplantation

    Zortress/Certican (everolimus)

    Myfortic (mycophenolic acid/mycophenolate sodium, USP)

    Neoral/Sandimmune (cyclosporine, USP Modified)

    Simulect (basiliximab)

  • Other

    Coartem/Riamet (artemether and lumefantrine)

    Famvir (famciclovir)

    Lamisil (terbinafine)

    Miacalcin/Miacalcic (salmon calcitonin)

    Reclast/Aclasta (zoledronic acid/zoledronic acid 5 mg)

    Vivelle Dot/Estradot (estradiol hemihydrate)

    Voltaren/Cataflam (diclofenac sodium/potassium)